Drug resistance in cancer therapy is major cause of mortality
The platform asked about a list of higher-risk conditions and contraindications, including pancreatitis, pancreatic cancer, insulin-dependent diabetes, hypoglycemia, medullary thyroid cancer history, MEN-2, liver failure or cirrhosis, chronic kidney disease, gallstones, recent gastric bypass, and thyroid issues
Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer
Two 12-week studies provide no information about what happens with extended use over months or years
Lopez to explore whether semaglutide injections could be viable for you